Absorption, distribution, metabolism and excretion	ADME
Area under the curve AUC ratio	AUC AUCR
Clinical Pharmacogenetics Implementation Consortium	CPIC
Cytochrome P450	CYP450
Drug–drug interaction	DDI
Fold error	FE
High-performance liquid chromatography	HPLC
Human-liver microsome 50% inhibitory concentration	HLM IC50
Reversible inhibition constant	Ki
Observed inactivation rate of the affected enzyme	kobs
Maximum inactivation rate constant	kinact
Inhibitor concentration causing half-maximal inactivation	KI
Mass spectrometry	MS
Nicotinamide adenine dinucleotide phosphate	NADPH
Physiologically based pharmacokinetic	PBPK
Area under the curve ratio	AUCR
Reversible inhibition	RI
Schisandrin A	SIA
Schisantherin A	STA
Schizandrol A	SZA
Schizandrol B	SZB
Tacrolimus	FK-506
Time-dependent inhibition	TDI
Traditional Chinese medicine	TCM
Wuzhi capsule	WZC